Neocis Introduces New Bone Reduction Feature to Yomi Robot

Neocis, a company focused on robot-assisted dental surgery, has announced the commercial launch of its latest bone reduction planning feature for the Yomi robotic dental surgery system. 

The United States Food and Drug Administration (FDA) cleared this bone reduction platform, Yomi’s newest feature, in November 2022. This technology reportedly enables dental professionals to use Yomi to precisely plan bone reduction using a patient’s CT scan and execute the treatment plan with the help of robotic guidance.

First FDA-Cleared Robotic System for Dental Surgery 

Yomi, the first FDA-cleared robotic system for dental surgery, helps clinicians in the planning and operative phases of dental implant placement via interactive digital planning and haptic guidance of surgical instrumentation. This technology has helped general dentists and specialists place more than 28,000 implants and perform upwards of 16,000 robot-guided cases.

Neocis receives new FDA clearance

With Yomi-guided alveoloplasty, clinicians are physically prevented from moving the cutting bur beyond the reduction boundaries outlined in the treatment plan. According to Neocis, the robotic assistance provides the capability for intraoperative treatment modifications, unobstructed visualization, irrigation, and palpation of the surgical site. Surgeons receive a clear virtual reference of how much bone has been removed, providing a time-saving and safe solution.

Yomi’s Client Testimonials 

“Yomi takes bone reduction to the next level,” said Dr Sanju Jose, a periodontist in the Baltimore-Washington metropolitan area and one of the first clinicians in the country to use this new feature in a live surgical setting. “After just a few cases, I knew this functionality would be a game-changer for us. Every time my team uses Yomi for ridge reduction, we look at each other and say, ‘this is amazing.’”

According to Dr Scott Clayhold, an oral and maxillofacial surgeon in the Seattle area, “Yomi saves me a bunch of time by allowing me to precisely plan every dimension of the reduction volume for each patient. Then, I have the clinical flexibility to take the bur where I want, knowing that Yomi will prevent me from going beyond the boundaries I’ve set in my plan. That’s the beauty of robot-guided surgery.”

Neocis’ new bone reduction feature is the company’s 14th FDA clearance, designed to help clinical teams throughout the planning and intraoperative phases of this procedure, so they can perform complex full-arch cases with confidence and efficiency. The robotic assistance enables intraoperative treatment modifications, allows for unobstructed visualization, irrigation, and palpation of the surgical site, and doesn’t require the clinician to reflect large flaps, which helps maintain blood supply to the bone.

Click here for more information on the Yomi Robot by Neocis.